In this analysis of known and emerging inhibitory checkpoint receptors in patients with cervical cancer, we observed that in addition to an increase in PD-1 and TIGIT, the emerging receptors Tim-3, LAG-3 and NKG2A were likewise upregulated. This evidence concerns the gene HAVCR2 and cervical carcinoma.